Milestone Pharmaceuticals Inc. (MIST) NASDAQ
1.32
-0.04(-2.94%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 169.44M |
| Enterprise Value | 154.77M |
| P/E Ratio | -2.52 |
| PEG Ratio | -0.19 |
| Price/Sales Ratio | 63.55 |
| Price/Book Ratio | 4.77 |
| Enterprise/Revenue | 100.55 |
| Enterprise/EBITDA | -2.84 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -38.32 |
| Operating Margin | -36.69 |
Management Effectiveness
| Return On Assets | -0.35 |
| Return On Equity | -3.39 |
Income Statement
| Revenue | 1.55M |
| Revenue/Share | 0.01 |
| Gross Profit | 1.43M |
| EBITDA | -62.14M |
| Net Income | -63.06M |
| Diluted EPS | -0.75 |
Balance Sheet
| Total Cash | 184.22M |
| Total Cash/Share | 1.41 |
| Total Debt | 137.33M |
| Total Debt/Equity | 3.81 |
| Current Ratio | 9.18 |
| Book Value Per Share | 0.28 |
Price History
| 52-Week Change | -23.7 |
| 52-Week High | 3.06 |
| 52-Week Low | 1 |
| Moving Average 50 Days | 1.66 |
| Moving Average 200 Days | 1.89 |
Statistics
| Average Volume | 2.01M |
| Shares Outstanding | 85.89M |
| % Held by Institutions | 35.52 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
